Enanta Pharma (ENTA) – Analyst Comments
-
JPMorgan Downgrades Enanta (ENTA) to Underweight, 'COVID Execution Standstill & Lengthy RSV Timelines Likely to Weigh Shares'
-
Jefferies Downgrades Enanta Pharmaceuticals (ENTA) to Hold, 'sidelines until we see real signs of progress'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ENTA Stock Lookup